Christopher Reading
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis 7
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Antibiotic Use and Resistance 2
- Biotechnology top 5%
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 7
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Synthesis and Catalytic Reactions 4
-
- Phenothiazines and Benzothiazines Synthesis and Activities 3
- Enzyme function and inhibition 2
-
- Synthesis and Biological Activity 2
- Co-authors
- Martin ColeT. H. FarmerSIMON E. BLANCHFLOWERJeremy R. EverettA. G. BROWNG. N. RolinsonJohn HoodDouglas Butterworth
- Journals
- The Journal of Antibiotics (7 papers)Journal of Antimicrobial Chemotherapy (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Christopher Reading
21 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Medicine 582
- Pharmacology 875
- Applied Microbiology and Biotechnology 58
- Biotechnology 125
- Pharmacology 92
Countries citing papers authored by Christopher Reading
This map shows the geographic impact of Christopher Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Reading more than expected).
Fields of papers citing papers by Christopher Reading
This network shows the impact of papers produced by Christopher Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Reading. The network helps show where Christopher Reading may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Christopher Reading, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 65 | |
| 2 | 1996 | 12 | |
| 3 | 1996 | 9 | |
| 4 | 1996 | 1 | |
| 5 | 1993 | 80 | |
| 6 | 1991 | 87 | |
| 7 | 1988 | 7 | |
| 8 | 1987 | 15 | |
| 9 | 1986 | 14 | |
| 10 | 1986 | 17 | |
| 11 | 1985 | 4 | |
| 12 | 1983 | 12 | |
| 13 | 1982 | 4 | |
| 14 | 1982 | 180 | |
| 15 | 1981 | 42 | |
| 16 | 1980 | 8 | |
| 17 | 1979 | 67 | |
| 18 | 1979 | 81 | |
| 19 | Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerusbreakdown → | 1977 | 574 |
| 20 | 1976 | 285 |
About Christopher Reading
Christopher Reading is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Organic Chemistry and Pharmacology, having authored 21 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Microbial Natural Products and Biosynthesis (7 papers), Synthesis and Catalytic Reactions (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers), Enzyme function and inhibition (2 papers), Antibiotic Use and Resistance (2 papers) and Synthesis and Biological Activity (2 papers). The work is most often cited by research in Molecular Medicine (582 citations), Pharmacology (875 citations), Applied Microbiology and Biotechnology (58 citations), Biotechnology (125 citations) and Pharmacology (92 citations). Christopher Reading has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Martin Cole, T. H. Farmer, SIMON E. BLANCHFLOWER, Jeremy R. Everett, A. G. BROWN, G. N. Rolinson, John Hood, Douglas Butterworth, Paul Hepburn and Andrew Fosberry. Their work appears in journals such as The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Drugs and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.